Investment Firm
Overview
BioLoomics is a biotechnology company that develops antibodies for cancer therapies.
Sep 19, 2023
Seed
Highlights
Location
Social
Participant Investors
8
BioLoomics raised $8700000 on 2023-09-19 in Seed Round
BioLoomics is a biotechnology company that develops antibodies for cancer therapies.
Company Funding History
4
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
May 30, 2019 | Seed Round - BioLoomics | - | 600.0K | |
Nov 21, 2019 | Grant - BioLoomics | - | 240.0K | |
May 11, 2021 | Pre Seed Round - BioLoomics | - | 575.0K | |
Sep 19, 2023 | Seed Round - BioLoomics | 9 | - | 8.7M |
Recent Activity
There is no recent news or activity for this profile.